Present Treatments & Hopeful Future Directions for ALS Pharmacotherapies
Worldwide Clinical Trials
MAY 30, 2024
Authors: Rich Worldwide Clinical Trials Exec. Director, Therapeutic Strategy Lead, Neuroscience & Lucie Undus, MD PhD, Exec. Director, Therapeutic Area Medical Lead. In the quest to shift ALS from terminal to treatable, we still have a long way to go. Since marketing authorization for the first breakthrough treatment in 1994, the steady increase in clinical trials reflects the community’s commitment to finding effective ALS treatments despite the numerous hurdles associated with clinic
Let's personalize your content